TIS 0.00% 0.0¢ tissue therapies limited

27.5m ulcers treated in 2010, page-59

  1. 1,771 Posts.
    The price point of Vitro-Gro being cheaper will also open the market up to those countries/organisations (hospitals) / people who could not previously afford those other products. This will open the market up to the 'untapped' market and remove unaffordability as a factor.

    DYOR
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.